Pure Global

Clinical Chemistry Analyzer HB1 - India CDSCO Medical Device Registration

Clinical Chemistry Analyzer HB1 is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/001079_470cd0499a1fd5ee3b4ea0e1d980d973_6a28f347e32b5c2d3c970b33db4eb622. This device is marketed under the brand name Skyla. The license holder is Kin Diagnostics, and it is classified as Device Class Class A. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class A
Clinical Chemistry Analyzer HB1
UID: IMP/IVD/2020/001079_470cd0499a1fd5ee3b4ea0e1d980d973_6a28f347e32b5c2d3c970b33db4eb622

Brand Name

Skyla

License Holder

Kin Diagnostics

Device Class

Class A

Approving Authority

CDSCO

Product Information

The skylaTM Clinical Chemistry Analyzer, together with its exclusive HB1 reagent disc series, offers a quick, easy and accurate method to measure various biochemical markers in whole blood, plasma, or serum. The skylaTM Clinical Chemistry Analyzer is operated in any manner different from those described in this manual, the analyzer may produce no or inaccurate results. If used outside safe design limits, the skylaTM Clinical Chemistry Analyzer may not function as intended and may be hazardous. The skylaTM Clinical Chemistry Analyzer should only be used with skylaTM HB1 series of reagent discs.

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing